| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.680 | 26.781 | 26.837 | 29.799 | 23.280 | 16.372 | - | - | - |
| Total Income - EUR | - | 6.680 | 26.781 | 26.837 | 29.799 | 23.280 | 16.372 | - | - | - |
| Total Expenses - EUR | - | 13 | 1.032 | 1.697 | 1.564 | 7.881 | 6.693 | - | - | - |
| Gross Profit/Loss - EUR | - | 6.667 | 25.749 | 25.141 | 28.234 | 15.398 | 9.679 | - | - | - |
| Net Profit/Loss - EUR | - | 6.467 | 24.945 | 24.336 | 27.340 | 14.992 | 9.371 | - | - | - |
| Employees | - | 0 | 0 | 0 | 0 | 2 | 1 | - | - | - |
Check the financial reports for the company - Prodecobio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 554 | 282 | - | - | - |
| Current Assets | - | 6.725 | 25.469 | 42.451 | 68.822 | 77.456 | 76.465 | - | - | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 113 | - | - | - |
| Receivables | - | 6.680 | 12.314 | 10.025 | 1.997 | 1.056 | 1.919 | - | - | - |
| Cash | - | 45 | 13.155 | 32.426 | 66.825 | 76.400 | 74.433 | - | - | - |
| Shareholders Funds | - | 6.511 | 24.997 | 42.089 | 68.614 | 76.558 | 75.156 | - | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | - | 214 | 471 | 363 | 208 | 1.452 | 1.591 | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3312 - 3312" | |||||||||
| CAEN Financial Year |
3312
|
|||||||||
Comments - Prodecobio Srl